2021 Outstanding Early Career Scientists

Published:November 19, 2021DOI:
      The Editorial Staff and the American Pharmacists Association are for the first time recognizing outstanding early career scientists for publishing their most original and significant scientific findings in the Journal of Pharmaceutical Sciences (JPharmSci®) in 2021. Those being recognized are the primary authors of articles who were either graduate students or within their first 10 years post-Ph.D. in a permanent appointment (i.e., an academic, foundation, government, or industrial scientist position) and published research articles that were recognized by the Editors in the period of October 1, 2020 to September 1, 2021 as one of the six monthly featured articles in an issue or as an article that appeared in one of the quarterly virtual issues and based on presenting the most original and significant scientific findings. Our purpose is to bring further attention to an individual's scientific research and achievements, and to publicly express our appreciation for their selection of JPharmSci® in which to publish their research findings.
      The 2021 Outstanding Early Career Scientists include: Alberto Berardi, DFE Pharma (Germany); Jill Coghlan, University of Michigan (Michigan); Suzanne M. D'Addio, Merck & Co. (Pennsylvania); Daniel Alan Davis, DisperSol Technologies, LLC (Texas); Vaibhav Deokar, Lupin Limited (India); Felix Huth, Novartis Pharma AG (Massachusetts); Hiroaki Iwata, Kyoto University (Japan); Hemanth K. Mamidi, Continuus Pharmaceuticals (Massachusetts); Alexandra Teleki, Uppsala University (Sweden); and Anh Quoc Vo, Hanoi University (Vietnam).
      Congratulations to all of these scientists and thank you to all of the scientists who publish their research findings in JPharmSci®!

      Declaration of Interests

      The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.